WallStreetZenWallStreetZen

NASDAQ: CMPS
Compass Pathways PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CMPS

Based on 3 analysts offering 12 month price targets for Compass Pathways PLC.
Min Forecast
$16.00+90.93%
Avg Forecast
$55.33+560.3%
Max Forecast
$120.00+1,331.98%

Should I buy or sell CMPS stock?

Based on 3 analysts offering ratings for Compass Pathways PLC.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CMPS stock forecasts and price targets.

CMPS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-03-01
lockedlocked$00.00+00.00%2023-12-12

1 of 1

Forecast return on equity

Is CMPS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is CMPS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CMPS revenue forecast

What is CMPS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$50.7M
Avg 2 year Forecast
$261.3M
Avg 3 year Forecast
$775.0M

CMPS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
CMPS$8.38$55.33+560.30%Strong Buy
INNV$3.95$6.50+64.56%Hold
EHAB$10.25$11.50+12.20%Buy
CCRN$17.50$20.80+18.86%Buy
PNTG$20.30$20.33+0.16%Buy
View Top Medical Care Facility Stocks

Compass Pathways Stock Forecast FAQ

Is Compass Pathways Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CMPS) stock is to Strong Buy CMPS stock.

Out of 3 analysts, 2 (66.67%) are recommending CMPS as a Strong Buy, 1 (33.33%) are recommending CMPS as a Buy, 0 (0%) are recommending CMPS as a Hold, 0 (0%) are recommending CMPS as a Sell, and 0 (0%) are recommending CMPS as a Strong Sell.

If you're new to stock investing, here's how to buy Compass Pathways stock.

What is CMPS's revenue growth forecast for 2026-2028?

(NASDAQ: CMPS) Compass Pathways's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Compass Pathways's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast CMPS's revenue for 2026 to be $3,256,327,710, with the lowest CMPS revenue forecast at $3,256,327,710, and the highest CMPS revenue forecast at $3,256,327,710. On average, 1 Wall Street analysts forecast CMPS's revenue for 2027 to be $16,782,612,042, with the lowest CMPS revenue forecast at $16,782,612,042, and the highest CMPS revenue forecast at $16,782,612,042.

In 2028, CMPS is forecast to generate $49,776,212,525 in revenue, with the lowest revenue forecast at $49,776,212,525 and the highest revenue forecast at $49,776,212,525.

What is CMPS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CMPS) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of N/A.

What is CMPS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CMPS price target, the average CMPS price target is $55.33, with the highest CMPS stock price forecast at $120.00 and the lowest CMPS stock price forecast at $16.00.

On average, Wall Street analysts predict that Compass Pathways's share price could reach $55.33 by Apr 1, 2025. The average Compass Pathways stock price prediction forecasts a potential upside of 560.3% from the current CMPS share price of $8.38.

What is CMPS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CMPS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.